Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY (J.R.M., B.S.F.).
The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Seattle (S.J.).
Circ Cardiovasc Qual Outcomes. 2021 Apr;14(4):e006769. doi: 10.1161/CIRCOUTCOMES.120.006769. Epub 2021 Mar 25.
Long-term health utility scores and costs used in cost-effectiveness analyses of cardiovascular disease prevention and management can be inconsistent, outdated, or invalid for the diverse population of the United States. Our aim was to develop a user friendly, standardized, publicly available code and catalog to derive more valid long-term values for health utility and expenditures following cardiovascular disease events.
Individual-level Short Form-12 version 2 health-related quality of life and expenditure data were obtained from the pooled 2011 to 2016 Medical Expenditure Panel Surveys. We developed code using the R programming language to estimate preference-weighted Short Form-6D utility scores from the Short Form-12 for quality-adjusted life year calculations and predict annual health care expenditures. Result predictors included cardiovascular disease diagnosis (myocardial infarction, ischemic stroke, heart failure, cardiac dysrhythmias, angina pectoris, and peripheral artery disease), sociodemographic factors, and comorbidity variables.
The cardiovascular disease diagnoses with the lowest utility scores were heart failure (0.635 [95% CI, 0.615-0.655]), angina pectoris (0.649 [95% CI, 0.630-0.667]), and ischemic stroke (0.649 [95% CI, 0.635-0.663]). The highest annual expenditures were for heart failure ($20 764 [95% CI, $17 500-$24 027]), angina pectoris ($18 428 [95% CI, $16 102-$20 754]), and ischemic stroke ($16 925 [95% CI, $15 672-$20 616]).
The developed code and catalog may improve the quality and comparability of cost-effectiveness analyses by providing standardized methods for extracting long-term health utility scores and expenditures from Medical Expenditure Panel Survey data, which are more current and representative of the US population than previous sources.
心血管疾病预防和管理的成本效益分析中使用的长期健康效用评分和成本对于美国多样化的人群来说可能不一致、过时或无效。我们的目的是开发一种用户友好、标准化、公开可用的代码和目录,以更有效地获得心血管疾病事件后的健康效用和支出的长期价值。
从 2011 年至 2016 年的医疗支出面板调查中获得个体水平的短式健康调查 12 版 2 健康相关生活质量和支出数据。我们使用 R 编程语言开发代码,从短式 12 版中估算偏好加权短式 6 维度效用评分,用于质量调整生命年计算,并预测年度医疗保健支出。结果预测因子包括心血管疾病诊断(心肌梗死、缺血性中风、心力衰竭、心律失常、心绞痛和外周动脉疾病)、社会人口因素和合并症变量。
效用评分最低的心血管疾病诊断是心力衰竭(0.635 [95%置信区间,0.615-0.655])、心绞痛(0.649 [95%置信区间,0.630-0.667])和缺血性中风(0.649 [95%置信区间,0.635-0.663])。年度支出最高的是心力衰竭($20764 [95%置信区间,$17500-$24027])、心绞痛($18428 [95%置信区间,$16102-$20754])和缺血性中风($16925 [95%置信区间,$15672-$20616])。
开发的代码和目录可以通过从医疗支出面板调查数据中提取长期健康效用评分和支出的标准化方法来提高成本效益分析的质量和可比性,这些方法比以前的来源更能反映美国人口的现状和代表性。